Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Sales: 2012-2024

Historic Return on Sales for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -0.15%.

  • Sunshine Biopharma's Return on Sales fell 3.00% to -0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.16%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.15% for FY2024, which is 4.00% up from last year.
  • Per Sunshine Biopharma's latest filing, its Return on Sales stood at -0.15% for FY2024, which was up 21.29% from -0.19% recorded in FY2023.
  • Sunshine Biopharma's Return on Sales' 5-year high stood at -0.15% during FY2024, with a 5-year trough of -54.44% in FY2021.
  • Moreover, its 3-year median value for Return on Sales was -0.19% (2023), whereas its average is -2.16%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by 1,546bps in 2021, then surged by 4,829bps in 2022.
  • Sunshine Biopharma's Return on Sales (Yearly) stood at -38.99% in 2020, then tumbled by 1,546bps to -54.44% in 2021, then surged by 4,829bps to -6.15% in 2022, then spiked by 597bps to -0.19% in 2023, then rose by 4bps to -0.15% in 2024.